SEC Form 4 · accession 0001209191-18-064335
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles W McHugh
Officer — Sr VP & Princ. Acctg Officer
Period of report
Dec 26, 2018
Accepted (ET)
Dec 28, 2018 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Dec 26, 2018 | M | 16,406 | $12.19 | A | 79,346 | D | |
| Ordinary Shares | holding | — | — | — | 1,000 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.19 | Dec 26, 2018 | M | 16,406 | D | — | Nov 30, 2024 | Ordinary Shares | 16,406 | 40,594 | D |
Explanation of responses
- F1The shares subject to the option were fully vested on 12/1/2018